Free shipping on all orders over $ 500

Recombinant Human Cuteaneous T-cell Attracting Chemokine/CCL27 (E.coli )

Cat. No. M21346

All AbMole products are for research use only, cannot be used for human consumption.

Recombinant Human Cuteaneous T-cell Attracting Chemokine/CCL27 (E.coli ) Structure
Size Price Availability Quantity
5ug USD 170 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
  • Purity: >96% , Endotoxin < 0.1 EU/µg
  • COA
  • MSDS
Biological Activity

Genus: Human
Expression system: E.coli
Purity: >96% by SDS-PAGE and HPLC analysis
Endotoxin: rHuCTACK/CCL27 is less than 0.1EU/µg as determined by LAL method
Molecular weight: about 10.1 kDa, a non-glycosylated polypeptide chain containing 88 amino acids
Storage and stability: Use a manually defrosted refrigerator and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C, supplied as is. 1 month, reconstituted at 2 to 8 °C under sterile conditions. 3 months, reconstituted at -20 to -70 °C under sterile conditions.


Bioactivity: Fully bioactive compared to standard. Bioactivity was determined by chemotaxis bioassay using CCR10 transfected BaF3 cells in the concentration range of 10-100 ng/ml.

Chemical Information
Solubility (25°C) Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL.
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Shanmugapriya Thangavadivel, et al. Oncotarget. CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma

[2] Lenie J van den Broek, et al. Tissue Eng Part A. Differential response of human adipose tissue-derived mesenchymal stem cells, dermal fibroblasts, and keratinocytes to burn wound exudates: potential role of skin-specific chemokine CCL27

[3] G Goteri, et al. Br J Dermatol. Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy

[4] Kimberly A Kraynyak, et al. Vaccine. Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques

[5] Takako Hirata, et al. J Biol Chem. Human P-selectin glycoprotein ligand-1 (PSGL-1) interacts with the skin-associated chemokine CCL27 via sulfated tyrosines at the PSGL-1 amino terminus

Related Cytokines and Growth Factors Products
Recombinant Human HGF (CHO-expressed)

Recombinant human Hepatocyte Growth Factor (rhHGF) , also known as hepatopoietin-A and scatter factor, is a pleiotropic mitogen belonging to the peptidase S1 family (plasminogen subfamily). It is produced by mesenchymal cells and acts on epithelial cells, endothelial cells and haemopoietic progenitor cells.

Recombinant Human RIPK3 Protein (E. coli, N-His)

RIPK3 is a kinase that controls necroptosis and apoptosis. In necroptosis, activated by TNF-α and ZBP1, RIPK3 phosphorylates MLKL, leading to membrane damage. Necroptosis is dependent on receptor-interacting protein kinase 3 (RIPK3), a protein shown to play an important role in experimental models of critical illness. RIPK3 promotes kidney tubular injury via mitochondrial dysfunction. The FAO-dependent RIPK3 mediates pathogenesis of acute lung injury.

Recombinant Influenza B Hemagglutinin/HA Protein (HEK293, C-His)

Recombinant Influenza B Hemagglutinin / HA Protein is a homotrimer that recognizes target cells in vertebrates and does so by binding to salivary acid-containing receptors on these cells. When it binds to the target cell, it causes the host inner membrane to fuse with the viral membrane, thereby facilitating the entry of the viral genome into the target cell.

Recombinant Human FGF-9 (E. coli)

Fibroblast Growth Factor-9 (FGF-9) is a heparin binding growth factor that belongs to the fibroblast growth factor (FGF) family. ED50 < 2.0 ng/ mL, determined by 3T3 cell proliferation assay, corresponding to > 5.0× 105 units/mg.

Recombinant Human CXCL13/BCA-1 (E. coli)

CXCL13, also known as B-lymphocyte chemoattractant (BLC), is a CXC chemokine that is constitutively expressed in secondary lymphoid organs. Recombinant human CXCL13 is a single non-glycosylated polypeptide chain containing 87 amino acids and mature human BCA-1 shares 64 % amino acid sequence similarity with the murine protein and 23–34 % amino acid sequence identity with other known CXC chemokines. Determined by a chemotaxis bioassay using human B cells, the biological activity is in a concentration range of 1.0-10 ng/ml.

  Catalog
Abmole Inhibitor Catalog




Keywords: Recombinant Human Cuteaneous T-cell Attracting Chemokine/CCL27 (E.coli ) supplier, Cytokines and Growth Factors, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.